MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrest.

AIMS Resuscitated out-of-hospital cardiac arrest (OHCA) patients who remain comatose after hospital arrival are at high risk of mortality due to anoxic brain injury. MicroRNA are small-non-coding RNA molecules ultimately involved in gene-silencing. They show promise as biomarkers, as they are stable in body fluids. The microRNA 9-3p (miR-9-3p) is associated with neurological injury in trauma and subarachnoid haemorrhage. METHODS AND RESULTS This post hoc analysis considered all 171 comatose OHCA patients from a single centre in the target temperature management (TTM) trial. Patients were randomized to TTM at either 33°C or 36°C for 24 h. MicroRNA-9-3p (miR-9-3p) was measured in plasma sampled at admission and at 28, 48, and 72 h. There were no significant differences in age, gender, and pre-hospital data, including lactate level at admission, between miR-9-3p level quartiles. miR-9-3p levels changed markedly following OHCA with a peak at 48 h. Median miR-9-3p levels between TTM 33°C vs. 36°C were not different at any of the four time points. Elevated miR-9-3p levels at 48 h were strongly associated with an unfavourable neurological outcome [OR: 2.21, 95% confidence interval (CI): 1.64-3.15, P < 0.0001). MiR-9-3p was inferior to neuron-specific enolase in predicting functional neurological outcome [area under the curve: 0.79 (95% CI: 0.71-0.87) vs. 0.91 (95% CI: 0.85-0.97)]. CONCLUSION MiR-9-3p is strongly associated with neurological outcome following OHCA, and the levels of miR-9-3p are peaking 48 hours following cardiac arrest.

[1]  Lin Yang,et al.  MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3β/Nrf2/ARE Signaling , 2021, Neuropsychiatric disease and treatment.

[2]  J. Soar,et al.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care , 2021, Intensive Care Medicine.

[3]  A. Pitkänen,et al.  Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury , 2021, International journal of molecular sciences.

[4]  M. Wise,et al.  Circulating Levels of Brain-Enriched MicroRNAs Correlate with Neuron Specific Enolase after Cardiac Arrest—A Substudy of the Target Temperature Management Trial † , 2020, International journal of molecular sciences.

[5]  L. Køber,et al.  Elevated miR-9 in Cerebrospinal Fluid Is Associated with Poor Functional Outcome After Subarachnoid Hemorrhage , 2020, Translational Stroke Research.

[6]  A. Mastroianni,et al.  Invisible hemolysis in serum samples interferes in NSE measurement , 2020, Tumori.

[7]  Y. Devaux,et al.  Circulating Levels of miR-574-5p Are Associated with Neurological Outcome after Cardiac Arrest in Women: A Target Temperature Management (TTM) Trial Substudy , 2019, Disease markers.

[8]  M. Bak,et al.  Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke , 2017, Biomarker Research.

[9]  M. Wise,et al.  Incremental Value of Circulating MiR-122-5p to Predict Outcome after Out of Hospital Cardiac Arrest , 2017, Theranostics.

[10]  Daehyun Baek,et al.  The Brain-Enriched MicroRNA miR-9-3p Regulates Synaptic Plasticity and Memory , 2016, The Journal of Neuroscience.

[11]  M. Wise,et al.  Neuron-Speci fi c Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33 C and 36 C , 2015 .

[12]  K. Claes,et al.  Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer. , 2015, Advances in experimental medicine and biology.

[13]  T. Cronberg,et al.  Serum neuron specific enolase – impact of storage and measuring method , 2014, BMC Research Notes.

[14]  B. Olde,et al.  The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest , 2014, Critical Care.

[15]  M. Wise,et al.  Targeted temperature management at 33°C versus 36°C after cardiac arrest. , 2013, The New England journal of medicine.

[16]  J. Nolan,et al.  Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort , 2013, Intensive Care Medicine.

[17]  D. O’Carroll,et al.  General Principals of miRNA Biogenesis and Regulation in the Brain , 2013, Neuropsychopharmacology.

[18]  M. Kuiper,et al.  Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. , 2012, American heart journal.

[19]  C. Callaway,et al.  Primary Outcomes for Resuscitation Science Studies: A Consensus Statement From the American Heart Association , 2011, Circulation.

[20]  R. Neumar,et al.  Consensus Process , 2022 .